1Saarialho-Kere U, Kerkela E, Jahkola T, et al. Epilysin (MMP- 28) expression is associated with cell proliferation during epithelial repair. Invest Dermatol, 2002, 119 (1): 14-21.
2Spinale FG, Coker ML, Heung LJ, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Girculation, 2000, 102 (16): 1944-1949.
3Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innaate immunity. Nat Revlmmunol, 2004, 4 (8): 617-629.
4Lessner SM, Galis ZS. Matrix metalloproteinases and vascular endothelium mononuclear cell close encounters. Trends Cardiovasc Med, 2004, 14 (3):105-111.
5Matsumura S, Iwanaga S, Mochizuki S, et al. Targeted dele tion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. Clin Invest, 2005, 115 (3):599-609.
6Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. Am Coil Cardiol, 2006, 47 (8 Suppl): C13-C18.
9Zeng B, Prasan A, Fung KC, et al. Elevated circulating levels of mstrix metalloprcteinase-9 and 2 in patients with symptomatic coronary arterydisease. Intern Med J, 2005, 35 (6): 331-335.
10Higo S, Uematsu M, Yamagishi M, et al. Elevation of plasma matrix metallopmteinase-9 in the culprit coronary artery in patients with acute myocardial infarction. Circulartion, 2005, 69 (10):1180-1185.
二级参考文献6
1Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I[J]. Circulation, 2003, 108(14):1664-1672.
2Kaartinen M, van der Wal AC, van der Loos CM, et al. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture[J]. J Am Coll Cardiol, 1998, 32(3): 606-612.
3Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T-lymphocytes: A role for CD40 signaling in plaque rupture [J]. Circ Res, 1997, 81(3): 448-454.
4Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina[J]. Lancet, 1997, 349(9050): 462-466.
5Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinases-9 and tissue inhibitor metalloproteinase-1 are increased in patients with acute coronary syndrome[J]. Am Heart J, 2001, 141(2): 211-217.
